Risk management of QT-prolonging drugs by community pharmacists by using a mobile electrocardiograph

Yakugaku Zasshi

Volumn 130, Issue 11, 2010, Pages 1597-1601

  Shinozaki, Kohki ^a  

^a Hikuma Pharmacy   (Japan)

Author keywords

Community pharmacy; Mobile electrocardiograph; QT prolongation

Indexed keywords

BENIDIPINE; CYTOCHROME P450 3A4; ERYTHROMYCIN; PREDNISOLONE; TACROLIMUS;

ARTICLE; CLINICAL ARTICLE; ELECTROCARDIOGRAPHY; ELECTROCARDIOGRAPHY MONITORING; FEMALE; GROUPS BY AGE; HUMAN; INTERMETHOD COMPARISON; PHARMACIST; PHARMACY; PRESCRIPTION; QT INTERVAL; QT PROLONGATION; RISK FACTOR; RISK MANAGEMENT;

AGED; ANTI-ARRHYTHMIA AGENTS; ANTI-BACTERIAL AGENTS; ANTIPSYCHOTIC AGENTS; COMMUNITY PHARMACY SERVICES; DRUG INTERACTIONS; ELECTROCARDIOGRAPHY; FEMALE; HISTAMINE ANTAGONISTS; HUMANS; LONG QT SYNDROME; RISK FACTORS; RISK MANAGEMENT; TORSADES DE POINTES;

EID: 78349286017     PISSN: 00316903     EISSN: 13475231     Source Type: Journal    
DOI: 10.1248/yakushi.130.1597     Document Type: Article

References (15)

1. Drew B. J., Ackerman M. J., Funk M., Gibler W. B., Kligfield P., Menon V., Philippides G. J., Roden D. M., Zareba W., Circulation, 121, 1047-1060 (2010).
2. Drolet B., Rousseau G., Daleau P., Cardinal R., Turgeon J., Circulation, 102, 1883-1885 (2000).
3. The Japanese Circulation Society, Circ. J., 71 (Suppl.), 1257-1270 (2007).
4. Kamiya K., Farumasia, 43, 1097-1102 (2007).
5. Ministry of Health, Labour and Welfare: 〈http://wwwhourei.mhlw.go. jp/hourei/doc/tsuchi/T091029I0030.pdf〉, cited 31 August, 2010.
6. ReadMyHeart PLUS manual and manufacturer data.
7. MacLaughlinN. B., Campbell R. W. F.,Murray A., Br. Heart J., 74, 84-89 (1995).
8. Sugiyama Y., Hisaka A., Ohno Y., Suzuki H., Maeda K., PharmaTribune, 1 (Suppl.), 2009.
9. Okumura T., Sakakibara M., Oguri M., Shimada S., Okada K., Sawamura A., Arai K., Horie M., Itou M., Ashihara T., Inagaki K., Abstracts of papers, the 17th Annual Meeting of Japanese Society of Pharmaceutical Health Care and Sciences, Gunma, September 2007, p. 357.
10. Hazama K., "Yakuzaishi no tameno Vital Sign," NANZANDO Co., Ltd., Tokyo, 2010.
11. Kasahara Y., J. Clin. Lab. Inst. Reag., 32, 3-8 (2009).
12. Kanbara K., Motomiya T., Takemura H., Tsunematsu N., Mochida Y., Abstracts of papers, the 104th Annual Meeting of the Japanese Society of Internal Medicine, Osaka, April 2007, p. 130.
13. The Japanese Circulation Society, Circ. J., 69 (Suppl.), 1253-1265 (2005).
14. Kamiya K., Saishin Igaku, 60, 2309-2316 (2005).
15. Ministry of Health, Labour and Welfare, 〈http://www.info.pmda.go.jp/ juutoku/file/jfm0905019.pdf〉, Pharmaceuticals and Medical Devices Agency Web, cited 25 May, 2010.